Low molecular mass chitosan as carrier for a hydrodynamically balanced system for sustained delivery of ciprofloxacin hydrochloride

Acta Pharmaceutica

Volumn 62, Issue 2, 2012, Pages 237-250

  Verma, Anurag ^a   Bansal, Ashok ^a   Ghosh, Amitava ^a   Pandit, Jayanta ^b  

^a IFTM   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

ciprofloxacin; hydrodynamically balanced capsules; low molecular mass chitosan; stomach specific release; xanthan gum

Indexed keywords

CHITOSAN; CIPROFLOXACIN; DRUG CARRIER; WATER; XANTHAN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HYDRODYNAMICS; MOLECULAR WEIGHT; SUSTAINED DRUG RELEASE;

EID: 84863431139     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0013-2     Document Type: Article

References (15)

1. N. Bhattarai, J. Gunn and M. Zhang, Chitosan-based hydrogels for controlled, localized drug delivery, Adv. Drug Del. Rev. 62 (2010) 83-99; DOI: 10.1016/j.addr.2009.07.019.
2. E. R. Gariépy and J. C. Leroux, Chitosan: A Natural Polycation with Multiple Applications, in Poly-saccharides for Drug Delivery and Pharmaceutical Applications (Eds. R. H. Marchessault, F. Ravene-lle and X. X. Zhu), ACS Symposium Series, Vol. 934, Washington 2006, pp. 243-259; DOI: 10.1021/bk-2006-0934.ch012.
3. T. W. Wong, Chitosan and its use in design of insulin delivery system, Recent Pat. Drug Del. Formul. 3 (2009) 8-25.
4. A. E. B. Yassin, A. A. Ibrahim and M. A. Abdulah, Chitosan beads as a new gastroretentive system of verapamil, Sci. Pharm. 74 (2006) 175-188.
5. S. Y. Park, K. S. Marsh and J. W. Rhim, Characteristics of different molecular weight chitosan films affected by the type of organic solvents, J. Food Sci. 67 (2002) 194-197; DOI: 10.1111/j.1365-2621.2002.tb11382.x.
6. J. Ali, S. Arora, A. Ahuja, A. K. Babbar, R. K. Sharma, R. K. Khar and S. Baboota, Formulation and development of hydrodynamically balanced system for metformin: In vitro and in vivo evaluation, Eur. J. Pharm. Biopharm. 67 (2007) 196-201; DOI: 10.1016/j.ejpb.2006.12.015
7. United States Pharmacopoeia 27/National Formulary 22, USP Pharmacopoeial Convention, Rockville (MD) 2000.
8. th ed., Marcel Dekker, New York 2002, pp. 67-92.
9. T. Higuchi, Rate of release of medicaments from ointment bases containing drugs in suspensions, J. Pharm. Sci. 50 (1961) 874-875; DOI: 10.1002/jps.2600501018.
10. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9.
11. A. M. Qandil, A. A. Obaidat, M. A. Mohammed Ali, B. M. Al-Taani, B. M. Tashtoush, N. D. Al-Jbour, M. M. Al Remawi, K. A. Al-Sou'od and A. A. Badwan, Investigation of the interactions in complexes of low molecular weight chitosan with ibuprofen, J. Solution Chem. 38 (2009) 695-712; DOI: 10.1007/s10953-009- 9405-4.
12. W. Erni and K. Held, The hydrodynamically balanced system: a novel principle of controlled drug release, Eur. Neurol. 27 (1987) 21-27; DOI: 10.1159/000116171.
13. Tm): A novel drug delivery system for oral use, Drug Dev. Ind. Pharm. 10 (1984) 313-339.
14. L. S. Wan, P. W. Heng and L. F. Wong, Relationship between swelling and drug release in a hy-drophilic matrix, Drug Dev. Ind. Pharm. 19 (1993) 1201-1210; DOI: 10.3109/03639049309063012.
15. P. J. Cox, K. A. Khan, D. L. Munday and J. Sujja-areevath, Development and evaluation of a multiple-unit oral sustained release dosage form for S (+)-ibuprofen: preparation and release kinetics, Int. J. Pharm. 193 (1999) 73-84; DOI: 10.1016/S0378-5173(99)00320-8.